Hjem › Overvægt › New Hampshire
Overvægt kliniske forsøg i New Hampshire
3 studier for Overvægt søger deltagere på steder i New Hampshire.
Officiel studietekst (engelsk)
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Dartmouth-Hitchcock Medical Center, Lebanon
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Dartmouth-Hitchcock Medical Center, Lebanon
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Stracskin, Portsmouth
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT06857942Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.